Browsing Nuclear Medicine by Subject "Metastasized castration-resistant prostate cancer (mCRPC)"
- UPSpace Home
- →
- Health Sciences
- →
- Nuclear Medicine
- →
- Browsing Nuclear Medicine by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Nuclear Medicine by Subject "Metastasized castration-resistant prostate cancer (mCRPC)"
Now showing items 1-1 of 1
-
(Springer, 2017-06)Prostate-specific membrane antigen radioligand therapy (PSMA-RLT) with 177Lu-PSMA holds great promise as a safe treatment option in patients with metastasized castration-resistant prostate cancer (mCRPC) with ...
Now showing items 1-1 of 1